Trulicity 1.5 mg/.5mL
Dulaglutide · INJECTION, SOLUTION · Eli Lilly and Company
Trulicity (dulaglutide) is a prescription injection used to treat type 2 diabetes and to reduce the risk of heart disease and stroke in patients with type 2 diabetes. It works by helping your body release more insulin when blood sugar is high and belongs to a class of medications called GLP-1 receptor agonists.
Key Facts
- Brand Name
- Trulicity
- Generic Name
- Dulaglutide
- NDC Code (Product)
0002-1434- Manufacturer
- Eli Lilly and Company
- Strength
- 1.5 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125469
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 09/18/2014
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Trulicity used for?
Trulicity (dulaglutide) is a prescription injection used to treat type 2 diabetes and to reduce the risk of heart disease and stroke in patients with type 2 diabetes. It works by helping your body release more insulin when blood sugar is high and belongs to a class of medications called GLP-1 receptor agonists.
Is Trulicity a controlled substance?
Trulicity is not classified as a controlled substance by the DEA.
What is the generic name for Trulicity?
The generic name for Trulicity is Dulaglutide. There are 4 other brand versions of Dulaglutide.
What is the NDC code for Trulicity 1.5 mg/.5mL?
The NDC (National Drug Code) for Trulicity 1.5 mg/.5mL is 0002-1434, listed by Eli Lilly and Company.